| 1 | Clot or Not? Reviewing the Reciprocal Regulation Between Lipids and Blood Clotting. (Zhang Z, Rodriguez M, Zheng Z) Arterioscler Thromb Vasc Biol 2024 Mar;44(3):533-544 10 Citations |
| 4 | Comparison of Prothrombin Complex Concentrate with Activated Factor VII Use for Bleeding Following Cardiopulmonary Bypass in Children. (Benson JW, Hraska V, Scott JP, Stuth EAE, Yan K, Zhang J, Niebler RA) World J Pediatr Congenit Heart Surg 2023 May;14(3):282-288 3 Citations |
| 1 | Impact of timing and dosing of four-factor prothrombin complex concentrate administration on outcomes in warfarin-associated intracranial hemorrhage. (Cicci CD, Weiss A, Dang C, Stanton M, Feldman R) Pharmacotherapy 2022 May;42(5):366-374 7 Citations |
| 1 | Comparison of 4-factor PCC reversal of apixaban and rivaroxaban versus warfarin for intracranial hemorrhage. (Pasciolla S, Wojcik K, Kavi T, Green D, Shaikh H, Jankowitz B, Igneri LA) J Thromb Thrombolysis 2022 Jul;54(1):74-81 6 Citations |
| 1 | Electronic clinical decision support to facilitate a change in clinical practice: Small details can make or break success. (Connor JP, Medow JE, Ehlenfeldt BD, Rose AE, Raife T) Transfusion 2020 Sep;60(9):1970-1976 4 Citations |
| 1 | Indications and Methods of Anticoagulation Reversal. (Holzmacher JL, Sarani B) Surg Clin North Am 2017 Dec;97(6):1291-1305 11 Citations |
| 1 | Peptides derived from MARCKS block coagulation complex assembly on phosphatidylserine. (Kastelowitz N, Tamura R, Onasoga A, Stalker TJ, White OR, Brown PN, Brodsky GL, Brass LF, Branchford BR, Di Paola J, Yin H) Sci Rep 2017 Jun 27;7(1):4275 16 Citations |
| 1 | 3-Factor Prothrombin Complex Concentrates in Infants With Refractory Bleeding After Cardiac Surgery. (Jooste EH, Machovec KA, Einhorn LM, Ames WA, Homi HM, Jaquiss RD, Lodge AJ, Levy JH, Welsby IJ) J Cardiothorac Vasc Anesth 2016 Dec;30(6):1627-1631 22 Citations |
| 1 | EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice. (Liang HP, Kerschen EJ, Hernandez I, Basu S, Zogg M, Botros F, Jia S, Hessner MJ, Griffin JH, Ruf W, Weiler H) Blood 2015 Apr 30;125(18):2845-54 74 Citations |
| 1 | Management of the bleeding patient receiving new oral anticoagulants: a role for prothrombin complex concentrates. (Baumann Kreuziger LM, Keenan JC, Morton CT, Dries DJ) Biomed Res Int 2014;2014:583794 44 Citations |
| 2 | Platelet and endothelial expression of clotting factors for the treatment of hemophilia. (Montgomery RR, Shi Q) Thromb Res 2012 May;129 Suppl 2(Suppl 2):S46-8 16 Citations |
| 2 | Alternative strategies for gene therapy of hemophilia. (Montgomery RR, Shi Q) Hematology Am Soc Hematol Educ Program 2010;2010:197-202 5 Citations |
| 1 | Abnormalities of prothrombin: a review of the pathophysiology, diagnosis, and treatment. (Meeks SL, Abshire TC) Haemophilia 2008 Nov;14(6):1159-63 47 Citations |
| 1 | Corneal activation of prothrombin to form thrombin, independent of vascular injury. (Ayala A, Warejcka DJ, Olague-Marchan M, Twining SS) Invest Ophthalmol Vis Sci 2007 Jan;48(1):134-43 14 Citations |
| 2 | Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells. (Sood R, Kalloway S, Mast AE, Hillard CJ, Weiler H) Blood 2006 Apr 15;107(8):3173-80 90 Citations |
| 1 | Clinical uses of plasma and plasma fractions: plasma-derived products for hemophilias A and B, and for von Willebrand disease. (Josephson CD, Abshire TC) Best Pract Res Clin Haematol 2006;19(1):35-49 16 Citations |
| 1 | Cellular immune responses in hemophilia: why do inhibitors develop in some, but not all hemophiliacs? (White GC 2nd, Kempton CL, Grimsley A, Nielsen B, Roberts HR) J Thromb Haemost 2005 Aug;3(8):1676-81 75 Citations |
| 1 | Thrombophilia and pregnancy failure: feto-maternal interactions in the vascular bed of the placenta. (Sood R, Kalloway S, Mast AE, Weiler H) Thromb Res 2005 Feb;115 Suppl 1:92-4 2 Citations |
| 1 | The partial thromboplastin time: defining an era in coagulation. (White GC 2nd) J Thromb Haemost 2003 Nov;1(11):2267-70 62 Citations |
| 1 | Embryogenesis and gene targeting of coagulation factors in mice. (Sood R, Weiler H) Best Pract Res Clin Haematol 2003 Jun;16(2):169-81 6 Citations |
| 1 | Seventeen years' experience with Autoplex/Autoplex T: evaluation of inpatients with severe haemophilia A and factor VIII inhibitors at a major haemophilia centre. (White GC 2nd) Haemophilia 2000 Sep;6(5):508-12 14 Citations |
| 1 | Mammalian recombinant coagulation proteins: structure and function. (White GC 2nd, Pickens EM, Liles DK, Roberts HR) Transfus Sci 1998 Jun;19(2):177-89 14 Citations |
| 1 | Treatment of the hemophilias. (Moll S, White GC 2nd) Curr Opin Hematol 1995 Sep;2(5):386-94 2 Citations |
| 1 | Multiple coagulation factor abnormalities in commercially available Passovoy-deficient plasma. (Foster PA, Montgomery RR, Endres-Brooks J) Blood 1992 Dec 15;80(12):3260-1 3 Citations |
| 1 | Protein C survival during replacement therapy in homozygous protein C deficiency. (Marlar RA, Sills RH, Groncy PK, Montgomery RR, Madden RM) Am J Hematol 1992 Sep;41(1):24-31 28 Citations |
| 1 | Clinical experience of a new monoclonal antibody purified factor IX: half-life, recovery, and safety in patients with hemophilia B. (Kim HC, McMillan CW, White GC, Bergman GE, Saidi P) Semin Hematol 1990 Apr;27(2 Suppl 2):30-5 24 Citations |
| 1 | Diagnosis and treatment of homozygous protein C deficiency. Report of the Working Party on Homozygous Protein C Deficiency of the Subcommittee on Protein C and Protein S, International Committee on Thrombosis and Haemostasis. (Marlar RA, Montgomery RR, Broekmans AW) J Pediatr 1989 Apr;114(4 Pt 1):528-34 194 Citations |
| 1 | Newborn haemostasis. (Montgomery RR, Marlar RA, Gill JC) Clin Haematol 1985 Jun;14(2):443-60 26 Citations |
| 1 | Endothelial cell synthesis of von Willebrand antigen II, von Willebrand factor, and von Willebrand factor/von Willebrand antigen II complex. (McCarroll DR, Levin EG, Montgomery RR) J Clin Invest 1985 Apr;75(4):1089-95 41 Citations |
| 1 | Cleavage of human von Willebrand factor by platelet calcium-activated protease. (Kunicki TJ, Montgomery RR, Schullek J) Blood 1985 Feb;65(2):352-6 69 Citations |
| 1 | Severe homozygous protein C deficiency. (Sills RH, Marlar RA, Montgomery RR, Deshpande GN, Humbert JR) J Pediatr 1984 Sep;105(3):409-13 115 Citations |
| 1 | Correlation between circulating levels of von Willebrand's antigen II and von Willebrand factor: discrimination between type I and type II von Willebrand's disease. (McCarroll DR, Ruggeri ZM, Montgomery RR) J Lab Clin Med 1984 May;103(5):704-11 22 Citations |
| 1 | The effect of DDAVP on plasma levels of von Willebrand antigen II in normal individuals and patients with von Willebrand's disease. (McCarroll DR, Ruggeri ZM, Montgomery RR) Blood 1984 Mar;63(3):532-5 21 Citations |
| 1 | Interaction of von Willebrand factor with human platelets in the plasma milieu. (Schullek J, Jordan J, Montgomery RR) J Clin Invest 1984 Feb;73(2):421-8 79 Citations |
| 1 | Coagulopathy of disseminated neuroblastoma. (Scott JP, Morgan E) J Pediatr 1983 Aug;103(2):219-22 17 Citations |
| 1 | Platelets have more than one binding site for von Willebrand factor. (Ruggeri ZM, De Marco L, Gatti L, Bader R, Montgomery RR) J Clin Invest 1983 Jul;72(1):1-12 |
| 1 | Clinical and physiologic studies of two siblings with prekallikrein (Fletcher factor) deficiency. (Hathaway WE, Wuepper KD, Weston WL, Humbert JR, Rivers RP, Genton E, August CS, Montgomery RR, Mass MF) Am J Med 1976 May 10;60(5):654-64 27 Citations |
| 1 | Changes associated with platelet aging. (Ginsburg AD, Aster RH) Thromb Diath Haemorrh 1972 Jul 31;27(3):407-15 48 Citations |
© 2026 Clinical & Translational Science Institute